Dr. Liang Schweizer: Creating Targeted Antibodies in Single Cells
#
English - August 20, 2022 05:00 - 52 minutes - 47.7 MB - ★★★★★ - 239 ratingsNatural Sciences Science Education biotech science life science plant biology agriculture agtech biology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Celine Halioua: Extending Health and Life, Starting with Dogs
Immunotherapies represent a powerful suite of treatments that co-opt the immune system to target deleterious cellular conditions. They have been effective with a series of cancers and other disorders. The problem is that development of new antibodies can be challenging for several technical reasons, but also because no two people are alike. Dr. Liang Schweizer of HiFiBio describes how her company is using single-cells and microfluidics to identify new antibodies that may be mobilized against discrete cellular targets, as well as what they have learned about heterogeneity between patients and how to identify specific biomarkers that could guide application of the most effective treatments.